Non-PVC IV Bags Market Report 2026

Non-PVC IV Bags Market Overview

• Non-PVC IV Bags market size has reached to $2.28 billion in 2025 • Expected to grow to $3.8 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Increasing Patient Traffic Enhance The Non-PVC IV Bags Market • Market Trend: Innovative Polyolefin Shrink Films Enhancing Safety and Sustainability in Non-PVC IV Bags • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Non-PVC IV Bags Market?

Non-PVC IV bags refer to bags that do not contain polyvinyl chloride (PVC) as a material and are used in healthcare settings to administer fluids, medications, and nutrients directly into a person's vein. They are widely used in hospitals and emergency medical services due to their resistance to chemicals, heat, and UV light, ensuring the quality and stability of IV fluids. The main types of non-PVC IV bags are single-chamber and multi-chamber. Single-chamber non-PVC IV bags are intravenous bags that contain only one compartment and are made from materials other than polyvinyl chloride (PVC). Different types of materials are used, such as ethylene vinyl acetate, polypropylene, copolyester ether, and others. It has both frozen mixture and liquid mixture content for several applications, including chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection, and others. These bags are used by several end-user industries, such as hospitals, clinics, emergency service centers, ambulatory surgical centers, and others.

What Is The Non-PVC IV Bags Market Growth Forecast?

The non-pvc iv bags market size is expected to see rapid growth in the next few years. It will grow to $3.8 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing demand for sustainable medical consumables, rising adoption of preservative-free IV solutions, expansion of targeted drug delivery therapies, growing investments in advanced infusion packaging, increasing regulatory focus on material safety. Major trends in the forecast period include increasing adoption of pvc-free medical packaging, rising demand for multi-chamber iv bags, growing use of chemically stable polymer materials, expansion of ready-to-use iv solutions, enhanced focus on drug compatibility.

Global Non-PVC IV Bags Market Segmentation

1) By Product: Single Chamber, Multi Chamber 2) By Material: Ethylene Vinyl Acetate, Polypropylene, Copolyester Ether, Other Materials 3) By Content: Ready-To-Use Sterile Fluids, Liquid Mixture 4) By Application: Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, Other Applications 5) By End User: Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Single Chamber: Standard Single Chamber Iv Bags, Flexible Single Chamber Iv Bags 2) By Multi Chamber: Dual Chamber Iv Bags, Triple Chamber Iv Bags, Multi-Camber Iv Bags (More Than Three Chambers)

What Is The Driver Of The Non-PVC IV Bags Market?

The increasing patient traffic within healthcare settings is expected to propel the growth of the non-PVC IV bags market going forward. Patient traffic refers to the flow or volume of patients seeking medical care or services within a healthcare facility, such as a hospital, clinic, or doctor's office. Healthcare admission are on higher demand for healthcare services, and changes in healthcare policies or insurance coverage. Non-PVC IV bags are required for patients due to concerns about the potential leaching of harmful chemicals from PVC materials into intravenous fluids, minimizing the risk of patient exposure to toxins. For instance, in January 2024, according to a report published by the National Health Service, a UK-based publicly funded healthcare system, 1.63 million patients initiated treatment, while over 2.3 million diagnostic tests were conducted in November 2023, maintaining significant pressure on emergency departments nationwide, where more than 2.1 million A (accident) and E (emergency) visits and over 547,000 emergency admissions occurred in December 2023. Therefore, the increasing patient traffic within healthcare settings is driving the growth of the non-PVC IV bags industry.

Key Players In The Global Non-PVC IV Bags Market

Major companies operating in the non-pvc iv bags market are Cardinal Health Inc., Pfizer Inc., Abbott Laboratories, Medline Industries LP, Becton Dickinson and Company, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Nipro Corporation, ICU Medical Inc., JW Life Science, Jiangxi Sanxin Medtec Co. Ltd., Angiplast Pvt. Ltd., Technoflex SA, Medi Pharma Plan Co. Ltd., Bausch Advanced Technologies Inc., PolyCine GmbH, Sealed Air Corporation, Kraton Corporation

Global Non-PVC IV Bags Market Trends and Insights

Major companies operating in the non-PVC IV bags market are developing innovative products, such as polyolefin shrink films to enhance safety, sustainability, and compatibility with various IV solutions. Polyolefin shrink films are durable, flexible, and clear packaging materials widely used for secure, tamper-resistant wrapping in food, consumer goods, electronics, and pharmaceuticals. Their non-toxic nature and high puncture resistance make them ideal for varied temperature conditions. For instance, in February 2024, Innovia Films, a UK-based manufacturer and supplier of biaxially-oriented polypropylene film, launched RayoFloat white APO. It is a floatable, white, low-density polyolefin shrink film designed for light-sensitive products. Its unique features include easy label detachment during PET recycling, aiding in high-quality PET flake production for food-grade use. The film's opaque nature provides light-blocking benefits, ideal for dairy, nutritional, and cosmetic products. Additionally, it supports sustainability with up to 20% post-industrial recycled content and complies with the EU's Packaging and Packaging Waste Regulation (PPWR).

What Are Latest Mergers And Acquisitions In The Non-PVC IV Bags Market?

In November 2023, Prange Group, a Germany-based company with a focus on sales and marketing of pharmaceuticals, and Adragos Pharma, a Germany-based contract development and manufacturing organization (CDMO), acquired Fresenius Kabi’s sterile pharmaceutical production site for an undisclosed amount. As a result of the acquisition, the company aims to expand its existing production network in Europe, North America, and Japan. Through this transaction, Fresenius Kabi will enter into a long-term supply agreement for products manufactured at the site. Fresenius Kabi is a Germany-based manufacturer of non-PVC IV bags.

Regional Outlook

North America was the largest region in the non-PVC IV bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Non-PVC IV Bags Market?

The non-PVC IV bags market consists of sales of sterilizable IV film or bag, IV tubing, and infusion administration sets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.